000 01705 a2200505 4500
005 20250514032303.0
264 0 _c20020926
008 200209s 0 0 eng d
022 _a0114-5916
024 7 _a10.2165/00002018-200225040-00005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClaessens, Angela A M C
245 0 0 _aDeterminants of headache in lansoprazole users in The Netherlands: results from a nested case-control study.
_h[electronic resource]
260 _bDrug safety
_c2002
300 _a287-95 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a2-Pyridinylmethylsulfinylbenzimidazoles
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAged
650 0 4 _aCase-Control Studies
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Interactions
650 0 4 _aEnzyme Inhibitors
_xadverse effects
650 0 4 _aHeadache
_xchemically induced
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aInfant
650 0 4 _aLansoprazole
650 0 4 _aMatched-Pair Analysis
650 0 4 _aMiddle Aged
650 0 4 _aNetherlands
650 0 4 _aOmeprazole
_xadverse effects
650 0 4 _aRisk Factors
650 0 4 _aSurveys and Questionnaires
700 1 _aHeerdink, Eibert R
700 1 _avan Eijk, Jacques T H M
700 1 _aLamers, Cornelis B H W
700 1 _aLeufkens, Hubert G M
773 0 _tDrug safety
_gvol. 25
_gno. 4
_gp. 287-95
856 4 0 _uhttps://doi.org/10.2165/00002018-200225040-00005
_zAvailable from publisher's website
999 _c11893392
_d11893392